Skin substitutes based on allogenic fibroblasts or keratinocytes for chronic wounds not responding to conventional therapy: a retrospective observational study
- 12 February 2014
- journal article
- research article
- Published by Wiley in International Wound Journal
- Vol. 13 (1) , 44-52
Abstract
Chronic wounds are an expression of underlying complex pathologies and have a high incidence. Skin substitutes may represent an alternative approach to treat chronic ulcers. The aim of this retrospective observational study was to evaluate the wound reduction using skin substitutes based on allogenic fibroblasts or keratinocytes in 30 patients not responding to conventional therapy. Wound bed was prepared, then keratinocytes on Laserskin® to treat superficial wounds or fibroblasts on Hyalograft 3DR to treat deep leg ulcers were applied, and finally wounds were treated with a secondary dressing composed of nanocrystalline silver. Once a week constructs were removed and new bioengineered products were applied, as well as nanocrystalline silver medication.In none of the cases under examination did any complications arise relating to the treatment. We also achieved a reduction in wound dimension and exudates, and an increase in wound bed score. Postoperative assessment shows a degree of healing that is statistically higher in the group treated with keratinocytes as compared with the fibroblast group.This retrospective study improves our understanding and defines the clinical indications for the various uses of the two types of skin substitutes.Keywords
This publication has 38 references indexed in Scilit:
- The role of skin substitutes in the management of chronic cutaneous woundsWound Repair and Regeneration, 2013
- A case of lower-extremity deep burn wounds with periosteal necrosis successfully treated by use of allogenic cultured dermal substituteJournal of Artificial Organs, 2010
- Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-β, and IL-8Journal of Artificial Organs, 2008
- Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substituteJournal of Artificial Organs, 2008
- Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower legJournal of Artificial Organs, 2008
- Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa*Journal of the American Academy of Dermatology, 2004
- Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitroJournal of Artificial Organs, 2003
- Randomized trial of four‐layer and two‐layer bandage systems in the management of chronic venous ulcerationWound Repair and Regeneration, 2003
- Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal testJournal of Artificial Organs, 2003
- Cutaneous tissue repair: Basic biologic considerations. IJournal of the American Academy of Dermatology, 1985